Professor Malcolm K Brenner - Overview of cell therapy for cancer in 2022 and beyond

Professor Malcolm K Brenner - Overview of cell therapy for cancer in 2022 and beyond

33:29 |

Related Videos

Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'

35:24

Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'

Professor David Wheeler - Cardiorenal protection in primary care: ACEi/ARB or both?

29:06

Professor David Wheeler - Cardiorenal protection in primary care: ACEi/ARB or both?

Professor Alice Cheng - SGLT inhibitors - are there no therapeutic limits

26:50

Professor Alice Cheng - SGLT inhibitors - are there no therapeutic limits

Professor Tamara Isakova - The FGF23 & Klotho axis – the need for a fine balance

24:25

Professor Tamara Isakova - The FGF23 & Klotho axis – the need for a fine balance

Prof Richard K. Burt - 'Haemopoietic stem cell transplantation in the management of MS'

33:43

Prof Richard K. Burt - 'Haemopoietic stem cell transplantation in the management of MS'

Dr Peter Libby - Cardiac atheroma at the limits – are we fighting the final battle?

30:12

Dr Peter Libby - Cardiac atheroma at the limits – are we fighting the final battle?

Dr E Ann Yeh - Longer-term safety of B-cell therapies in MS

28:12

Dr E Ann Yeh - Longer-term safety of B-cell therapies in MS

Prof Melanie Davies - 'Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes?'

26:43

Prof Melanie Davies - 'Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes?'

Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome?

23:18

Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome?

Dr Peter Libby - Cardiac atheroma at the limits – are we fighting the final battle?

7:26

Dr Peter Libby - Cardiac atheroma at the limits – are we fighting the final battle?

Cardiology, Diabetes & Nephrology At the Limits 2023 | Available to view now

0:33

Cardiology, Diabetes & Nephrology At the Limits 2023 | Available to view now

Dr Aruna Pradhan - Have we reached the limits of lipid lowering? What next? - Full version

20:49

Dr Aruna Pradhan - Have we reached the limits of lipid lowering? What next? - Full version

Professor Carel le Roux - 'How the gut talks to the brain and protects the heart and kidneys'

23:49

Professor Carel le Roux - 'How the gut talks to the brain and protects the heart and kidneys'

Dr Erin Bohula May - 'At the limits of lipid management – statins to PCSK9 inhibitors'

26:44

Dr Erin Bohula May - 'At the limits of lipid management – statins to PCSK9 inhibitors'

Professor David Clifford - 'PML and multiple sclerosis'

37:00

Professor David Clifford - 'PML and multiple sclerosis'

Professor Katy Rezvani - CAR-NK therapy

26:44

Professor Katy Rezvani - CAR-NK therapy

Dr David Rog - PML in MS

41:36

Dr David Rog - PML in MS

Dr Aruna Pradhan - Have we reached the limits of lipid lowering? What next? - Summary presentation

11:59

Dr Aruna Pradhan - Have we reached the limits of lipid lowering? What next? - Summary presentation

Professor Sonia Anand - Clotting at the limits: the NOAC generation! - Full version

18:27

Professor Sonia Anand - Clotting at the limits: the NOAC generation! - Full version

Professor John Deanfield - Primordial cardiology in youth – what are the limits? (English)

40:32

Professor John Deanfield - Primordial cardiology in youth – what are the limits? (English)